December 15th, 2015

WuXi Biologics CEO expects approval for Covid-19 antibody treatment 'late this year or early next year'

WuXi Biologics has signed more than 10 deals with clients to research antibodies that can potentially deliver treatment for the coronavirus.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.